Evidence map›Paper›PMID 41150434›Full record

ReviewVaccines2025

Health Technology Assessment of mRNA Vaccines: Clinical, Economic, and Public Health Implications.

Giovanni Genovese, Caterina Elisabetta Rizzo, Cristina Genovese

Abstract readReview
In one paragraph

Review in Vaccines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Giovanni GenoveseDepartment of Prevention, Local Health Authority of Messina, 98123 Messina, Italy.ORCID 0009-0007-0251-8144
Caterina Elisabetta RizzoDepartment of Prevention, Local Health Authority of Messina, 98123 Messina, Italy.ORCID 0009-0002-7503-008X
Cristina GenoveseDepartment of Biomedical, Dental and Morphological and Functional Imaging Sciences, University of Messina, 98124 Messina, Italy.ORCID 0000-0001-9282-1030

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Health Technology Assessment (HTA) is a multidimensional and multidisciplinary approach for analyzing the medical-clinical, social, organizational, economic, ethical, and legal implications of a technology, through the evaluation of multiple dimensions such as efficacy, safety, costs, and social-organizational impact. In the healthcare context, "technology" refers to any tool-including pharmaceuticals (or, in this case, vaccines)-that is applied to healthcare practice. HTA focuses on assessing both the real and potential effects of a given technology, either prospectively or throughout its life cycle, as well as the consequences that the introduction or exclusion of an intervention may have on the healthcare system, the economy, and society at large.

Indexed as

economic impactHTAmRNA vaccinespublic health

Identifiers

PMID41150434
PMCPMC12568131

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.